[1] 中国防治恶性高热专家共识工作组. 中国防治恶性高热专家共识(2020版)[J].中华麻醉学杂志,2021,41(1):20-25. DOI: 10.3760/cma.j.cn131073.20210102.00107. [2] Li Z, Liu K, Guo X: Dantrolene available in China for malignant hyperthermia treatment[J]. Anesthesiology, 2022,136(3):515-516. [3] 韩永正, 郭向阳. 国产注射用丹曲林钠用于恶性高热抢救规范化管理的个人建议[J].中华麻醉学杂志,2021,41(1):16-19. DOI: 10.3760/cma.j.cn131073.20201207.00106. [4] Cain CL, Riess ML, Gettrust L, et al. Malignant hyperthermia crisis: optimizing patient outcomes through simulation and interdisciplinary collaboration[J]. AORN J, 2014,99(2):301-308; quiz 309-311. DOI: 10.1016/j.aorn.2013.06.012. [5] Mejía V, Gonzalez C, Delfino AE, et al. Acquiring skills in malignant hyperthermia crisis management: comparison of high-fidelity simulation versus computer-based case study[J]. Braz J Anesthesiol, 2018,68(3):292-298. DOI: 10.1016/j.bjan.2018.01.005. [6] 曹锡梅, 崔慧林, 蔡玉瑾, 等. 基于情景教学法的线上教学方式在留学生组织学与胚胎学教学中的应用[J].中华医学教育杂志,2021,41(10):896-899. DOI: 10.3760/cma.j.cn115259-20210202-00156. [7] Ebbitt L, Johnson E, Herndon B, et al. Suspected Malignant Hyperthermia and the Application of a Multidisciplinary Response[J]. Healthcare (Basel), 2020,8(3):328.DOI: 10.3390/healthcare8030328. [8] Sousa CS, Bispo DM, Cunha AL, et al. Educational intervention on malignant hyperthermia with nursing professionals of the operating room[J]. Rev Esc Enferm USP, 2015,49(2):292-297. DOI: 10.1590/S0080-623420150000200015. [9] Quick J, Murthy R, Goyal N, et al. Malignant hyperthermia: an anesthesiology simulation case for early anesthesia providers[J]. MedEdPORTAL, 2017,13:10550. DOI: 10.15766/mep_2374-8265.10550. [10] Ho PT, Carvalho B, Sun EC, et al. Cost-benefit analysis of maintaining a fully stocked malignant hyperthermia cart versus an initial dantrolene treatment dose for maternity units[J]. Anesthesiology, 2018,129(2):249-259. DOI: 10.1097/ALN.0000000000002231.. [11] 李春玲, 黄长盛, 郭曲练, 等. 临床麻醉学课程思政的设计与实施效果[J].中华医学教育杂志,2023,43(9):659-662. DOI: 10.3760/cma.j.cn115259-20221008-01275. [12] 何征宇, 徐侨翌, 李尹娇枝, 等. 案例教学法联合情景模拟教学法在住院医师规范化培训中的应用[J].临床麻醉学杂志,2020,36(8):813-814. DOI: 10.12089/jca.2020.08.020. |